Renata Cífková

Q: What Schools Are Affiliated With Renata Cífková

Renata Cífková is affiliated with the following schools: Charles University, Memorial University of Newfoundland

Renata Cífková's AcademicInfluence.com Rankings

Renata Cífková

Medical

#2688

World Rank

#3119

Historical Rank

Cardiology

#254

World Rank

#260

Historical Rank

medical Degrees

Download Badge

Medical

Renata Cífková's Degrees

Doctorate Medicine Charles University

Why Is Renata Cífková Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Renata Cífková's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007) (9420)
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012) (6922)
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (5476)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (2017) (5238)
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults (2017) (3677)
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants (2016) (3648)
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (3077)
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants (2016) (2659)
2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension (2003) (2640)
European guidelines on cardiovascular disease and prevention in clinical practice. (2003) (2501)
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). (2003) (2476)
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. (2007) (1965)
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). (2011) (1677)
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants (2017) (1563)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document (2009) (1452)
Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) (2007) (1141)
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. (2013) (1115)
Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) (2007) (1040)
Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) (2007) (1040)
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. (2018) (1035)
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. (2004) (1028)
The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) (2013) (991)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. (2007) (965)
2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007) (921)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit (2007) (911)
[European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)]. (2013) (876)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit (2007) (869)
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries (2016) (863)
A century of trends in adult human height (2016) (861)
European guidelines on cardiovascular disease prevention in clinical practice: full text (2005) (840)
The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy (2012) (788)
2013 ESH/ESC Guidelines for the management of arterial hypertension (2013) (754)
ESHRE Guideline: management of women with premature ovarian insufficiency. (2016) (720)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (2017) (713)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. (2009) (707)
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. (2015) (595)
European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts) (2003) (592)
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants (2021) (585)
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension (2014) (579)
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. (2014) (568)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial (2017) (558)
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. (2009) (528)
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the Europe (2010) (520)
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry (2019) (471)
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (2004) (412)
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. (2003) (368)
Rising rural body-mass index is the main driver of the global obesity epidemic in adults (2019) (300)
[Management of high blood pressure in children and adolescents: Recommendations of the European Society of hypertension]. (2010) (284)
Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. (2000) (260)
A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) (252)
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. (2013) (252)
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). (2004) (212)
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension (2012) (200)
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels (2019) (183)
Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. (2011) (180)
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. (2019) (177)
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. (2019) (177)
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. (2015) (174)
Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. (2010) (142)
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants (2020) (138)
The metabolic syndrome in hypertension: European society of hypertension position statement (2008) (138)
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331288 participants (2015) (99)
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology (2015) (98)
Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013. (2017) (96)
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. (2007) (91)
Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. (2011) (89)
Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008 (2010) (88)
Blood pressure around the menopause: a population study (2008) (85)
Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey (2015) (81)
Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists (2021) (80)
Mechanisms of hypertension in the cardiometabolic syndrome (2009) (79)
Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys. (2017) (78)
Repositioning of the global epicentre of non-optimal cholesterol (2020) (77)
Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. (2014) (75)
Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants (2018) (70)
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. (2019) (70)
Cardiovascular risk factors in young Czech females with polycystic ovary syndrome. (2003) (70)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. (2014) (69)
Dyslipidemia and Cardiovascular Disease in Women (2015) (68)
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2021) (68)
Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007 (2014) (67)
Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01 (2004) (65)
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study (2013) (64)
Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population (2016) (56)
Low blood pressure during the acute period of ischemic stroke is associated with decreased survival (2015) (54)
Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study (2004) (52)
Hypertensive complications of pregnancy: A clinical overview. (2017) (50)
Relationship between measures of central and general adiposity with aortic stiffness in the general population. (2014) (50)
Threshold for diagnosing hypertension by automated office blood pressure using random sample population data (2016) (46)
Kardiovize Brno 2030, a prospective cardiovascular health study in Central Europe: Methods, baseline findings and future directions (2018) (46)
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence (2014) (44)
Large artery stiffness and pulse wave reflection: Results of a population‐based study (2005) (44)
The association between low 25-hydroxyvitamin D and increased aortic stiffness (2012) (44)
The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension. (2017) (43)
Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. (2020) (43)
Arterial stiffness parameters: how do they differ? (2013) (38)
The obesity paradox and survivors of ischemic stroke. (2015) (38)
Mild hyperhomocysteinaemia is associated with increased aortic stiffness in general population (2006) (37)
Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update (2016) (36)
Valsartan and atenolol in patients with severe essential hypertension (1998) (36)
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries (2019) (35)
Lower-extremity arterial stiffness vs. aortic stiffness in the general population (2013) (35)
Educational level and risk profile and risk control in patients with coronary heart disease (2016) (35)
Relation of central and brachial blood pressure to left ventricular hypertrophy. The Czech Post-MONICA Study (2010) (34)
Prevalence základních kardiovaskulárních rizikových faktorů v české populaci v letech 2006-2009. Studie Czech post-MONICA (2011) (33)
Quality of Life Predictors in Chronic Stable Post-Stroke Patients and Prognostic Value of SF-36 Score as a Mortality Surrogate (2015) (33)
ESHRE Guideline: management of women with premature ovarian (2016) (33)
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight (2020) (30)
Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach. (2019) (29)
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. (2016) (29)
A novel oscillometric device for peripheral arterial disease screening in everyday practice. The Czech-post MONICA study. (2011) (27)
Large artery stiffness and carotid flow pulsatility in stroke survivors (2014) (27)
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study (2018) (26)
30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985 – 2016/17 (2020) (25)
EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTRES (2007) (25)
10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020 (2020) (24)
A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension. (1997) (24)
Reference values of cardio-ankle vascular index in a random sample of a white population (2017) (23)
Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. (2021) (23)
The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease. (2016) (23)
The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease. (2019) (22)
N-terminal pro B-type natriuretic peptide as prognostic marker for mortality in coronary patients without clinically manifest heart failure (2009) (21)
Evaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension (2000) (20)
Cyclosporin-induced hypertension. (2001) (20)
The interaction of endothelial nitric oxide synthase polymorphism and current smoking in terms of increased arterial stiffness. (2010) (20)
Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey. (2018) (20)
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022) (19)
Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population (2016) (19)
Arterial hypertension as a public health issue in the Czech Republic (2005) (18)
The effect of an acute fat load on endothelial function after different dietary regimens in young healthy volunteers. (2002) (18)
[Longitudinal trends in major cardiovascular disease risk factors in the Czech population]. (2004) (17)
Intima‐media Thickness of Carotid Arteries in Borderline Hypertensives (1999) (17)
Positive effects of antihypertensive treatment on aortic stiffness in the general population (2014) (17)
A high ankle-brachial index is associated with increased aortic pulse wave velocity: the Czech post-MONICA study (2011) (16)
A Comparison of the Effects of Mibefradil and Atenolol on Regression of Left Ventricular Hypertrophy in Hypertensive Patients (1998) (16)
Synergistic effect of low K and D vitamin status on arterial stiffness in a general population. (2017) (16)
The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome. (2016) (16)
Hypertension and Reproduction (2020) (16)
Doporučení diagnostických a léčebných postupů u arteriálníhypertenze - verze 2007 (2008) (15)
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (2021) (14)
Synergistic effect of angiotensin II type 1 receptor and endothelial nitric oxide synthase gene polymorphisms on arterial stiffness (2008) (14)
Current and past smoking patterns in a Central European urban population: a cross-sectional study in a high-burden country (2016) (14)
Peripartum management of hypertension. A position paper of the ESC Council on Hypertension and the European Society of Hypertension. (2019) (14)
Hypertension in the metabolic syndrome: summary of the new position statement of the European Society of Hypertension. (2009) (14)
Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients. (2015) (13)
Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events? (2022) (13)
The quality of secondary prevention of coronary heart disease in Czech patients in the EURO-ASPIRE III survey. (2008) (13)
Comparison of three office blood pressure measurement techniques and their effect on hypertension prevalence in the general population. (2019) (12)
Comparison of noninvasive assessments of central blood pressure using general transfer function and late systolic shoulder of the radial pressure wave. (2014) (12)
Doporučení pro léčbu závislosti na tabáku (2005) (12)
Blood pressure control and risk profile in poststroke survivors: a comparison with the general population (2015) (11)
Serum Vitamin D Status, Vitamin D Receptor Polymorphism, and Glucose Homeostasis in Healthy Subjects (2017) (11)
Blood pressure, endothelial function and circulating endothelin concentrations in liver transplant recipients (2001) (11)
[European Guidelines on Cardiovascular Disease Prevention in the Clinical Practice. Third work group of the european societies and other societies on cardiovascular disease prevention in the clinical practice]. (2004) (11)
Why we are not able to find the coronary heart disease gene - apoE as an example. (2010) (11)
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (11)
The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker? (2020) (11)
The metabolic syndrome in hypertension: Diagnostic and therapeutic implications (2007) (10)
Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients. (2018) (10)
Update on Hypertension Management: Treatment of hypertension in patients with type 2 diabetes mellitus (2006) (10)
Association of intima-media thickness of carotid arteries with remnant lipoproteins in men and women. (2015) (10)
Why is the treatment of hypertension in pregnancy still so difficult? (2011) (10)
Cardiovascular Sequels of Hypertension in Pregnancy (2018) (9)
Myopatie asociovaná se statiny: klinické doporučení Slovenskej asociácie aterosklerózy a České společnosti pro aterosklerózu (2016) (8)
[Advantages and disadvantages of ECG diagnosis in left ventricular hypertrophy]. (2002) (8)
Stanovisko výboru České společnosti pro aterosklerózu k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2019 (2019) (8)
Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls. (2015) (8)
The burden of hypertension and inadequate control in populations. (2006) (8)
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from twenty four European countries (2016) (8)
The standard of secondary prevention of stroke in Czech patients in the EUROASPIRE III Study - Stroke Specific Module (2008) (8)
European Society of Hypertension Scientific Newsletter: Update on Hypertension Management: Prevention of type 2 diabetes mellitus with antihypertensive drugs (2006) (8)
Stručný souhrn doporučení pro dlouhodobou péči o nemocné po infarktu myokardu (2019) (8)
Epidemiology and risk of hypertension (2009) (8)
Hypertension in pregnancy: recommendations for diagnosis and treatment (2000) (8)
[Hypertension and arrhythmia]. (1988) (7)
(The prevalence of major cardiovascular risk factors in the Czech population in 2015-2018. The Czech post-MONICA study) (2020) (7)
Success and failure of cardiovascular disease prevention in Czech Republic over the past 30 years. Czech part of the EUROASPIRE I-IV surveys. (2017) (7)
Decreased prevalence and improved control of hypertension in the Czech population (1999) (7)
[Czech atherosclerosis society guidelines for the diagnosis and treatment of dyslipidemia in adults]. (2007) (7)
Mood disorders impaired quality of life but not the mortality or morbidity risk in stable coronary heart disease patients (2020) (7)
Availability and use of home blood pressure measurement in the Czech general population (2014) (7)
Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness (2019) (7)
[Development of smoking habits in the population of the Czech Republic from 1985 to 1997/98]. (2000) (6)
A comparison of secondary prevention practice in poststroke and coronary heart disease patients. (2016) (6)
Summary of the European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): Prepared by the Czech Society of Cardiology (2014) (6)
[Longitudinal trends of total and HDL cholesterol in a representative population sample in the Czech Republic]. (2000) (6)
The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients. (2020) (6)
Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry. (2019) (6)
Prevalence and Risk of Hypertension in Renal Disease – Data from the Czech Registry of Renal Biopsies (2008) (6)
Differential effect of metabolic syndrome on various parameters of arterial stiffness (2015) (6)
D37 Comparison of the angiotensin II antagonist valsartan with the β-blocker atenolol in patients with severe essential hypertension (1997) (6)
The association between subclinical atherosclerosis in carotid arteries and Connexin 37 gene polymorphism (1019C>T; Pro319Ser) in women. (2011) (5)
The prognostic importance of subclinical heart failure in stable coronary heart disease patients (2020) (5)
The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A2. (2015) (5)
Serum Bilirubin in the Czech Population　- Relationship to the Risk of Myocardial Infarction in Males. (2020) (5)
[Recommendations for the treatment of tobacco dependence]. (2005) (5)
The risk profile of patients with acute coronary syndrome treated at IKEM between 2006 and 2013 (2017) (5)
Stanovisko výboru ČSAT k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2011 (2013) (5)
Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: data from the MedPed CZ database and the Czech population. (2011) (5)
Carotid intima-media thickness in young survivors of acute myocardial infarction. (2012) (5)
[Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011]. (2013) (5)
Hypertension as a Cardiovascular Risk Factor (2019) (5)
Treatment of hypertension in ptients with type-2 diabetes mellitus (2006) (5)
Serum Bilirubin Concentrations and the Prevalence of Gilbert Syndrome in Elite Athletes (2022) (5)
Reference values of retinal microcirculation parameters derived from a population random sample. (2020) (5)
[Hypertension and hypercholesterolemia in the Czech population]. (2018) (4)
Residual cardiovascular risk in patients with stable coronary heart disease over the last 16 years (Czech part of the EUROASPIRE I-IV surveys). (2017) (4)
Sports and Exercise for Cardiovascular Health (2012) (4)
European guidelines on cardiovascular disease prevention in clinical practice: past, present, and future: a need for joint forces. (2008) (4)
ESH statement on detection and punishment of abstract fraud and poster plagiarism (2005) (4)
[Practice guidelines 2007 for the treatment of arterial hypertension]. (2007) (4)
[Czech Atherosclerosis Society Guidelines for the diagnosis and treatment of dyslipidemias in adults]. (2007) (4)
State of secondary prevention in Czech coronary patients in the EUROASPIRE IV study (2014) (4)
Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity (2021) (4)
[Diagnosis and treatment of arterial hypertension. 2012 Guidelines of the Czech Hypertension Society]. (2012) (4)
[European practice guidelines on prevention of cardiovascular diseases: executive summary]. (2008) (4)
Sex differences in hypertension. Do we need a sex-specific guideline? (2022) (4)
Alcohol and cardiovascular disease: Position Paper of the Czech Society of Cardiology. (2019) (4)
Tobacco use and some characteristics of tobacco users. Preliminary results of ‘‘Kardiovize Brno 2030 (2014) (4)
Monday, 27 August 2012 (2012) (3)
Hypovolaemia-induced metabolic dysfunction, mediated in part by aldosterone and angiotensin. (2009) (3)
Heart and vessel hypertrophy in hypertension: possibilities of regression. (1987) (3)
[Recommendations for the diagnosis and therapy of hyperlipoproteinemia in childhood and adolescence developed by the Committee of the Czech Society for Atherosclerosis]. (1998) (3)
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. (2010) (3)
Association between endothelial NO synthase polymorphism (rs3918226) and arterial properties (2012) (3)
Prevalence hlavních rizikových faktorů kardiovaskulárních onemocnění v české populaci v letech 2015-2018. Studie Czech post-MONICA (2020) (3)
Primary aldosteronism in a general population sample. The Czech post-MONICA study (2020) (3)
Treatment of Hypertension in patients with type-2 diabetes mellitus. (2006) (3)
The Prognostic Importance of Impaired Fasting Glycemia in Chronic Coronary Heart Disease Patients. (2018) (3)
Should 24-Hour Ambulatory Blood Pressure Monitoring Become Part of Regular Checkup in Women With Previous Preeclampsia? (2018) (3)
Antihypertensive efficacy and safety of verapamil SR/trandolapril (240/2 mg) in patients insufficiently pretreated with verapamil SR 240 mg monotherapy. (1999) (3)
Behçet’ Disease (‘Silk Route Disease’) and Mitral Valve Prolapse (1998) (3)
Which serum uric acid levels are associated with increased cardiovascular risk in the general adult population? (2020) (3)
Antiplatelet and Lipid-lowering Drugs in Hypertension. (2014) (3)
Exercise testing in hypertensive patients for assessing the cardiovascular protective potential of antihypertensive drugs (2013) (2)
The changing spectrum of risk factors for coronary heart disease (2009) (2)
The changes in achievement of target LDL-cholesterol levels between 2006 and 2017 in Czech patients with chronic coronary heart disease (2019) (2)
The heart in hypertension and arrhythmias. (1990) (2)
Arterial Hypertension and Cardiovascular Risk (2018) (2)
The DRD2/ANKK1 Taq1A polymorphism is associated with smoking cessation failure in patients with coronary heart disease. (2015) (2)
7C.06: SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS AND INCREASED AORTIC STIFFNESS IN A GENERAL POPULATION (2015) (2)
Reference values of cardio-ankle vascular index in a random sample of a Caucasian population (2017) (2)
[Hypertension as a risk factor for the development of obstructive peripheral artery disease]. (1980) (2)
30-YEAR TRENDS IN BLOOD PRESSURE, PREVALENCE, AWARENESS, TREATMENT AND CONTROL OF HYPERTENSION IN THE CZECH REPUBLIC. THE CZECH MONICA AND CZECH POST-MONICA STUDIES (2019) (2)
Prevalence of Gilbert syndrome and UGT1A1*28 status in the Czech population, and their relationship to ischemic heart disease (2014) (2)
22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts (2015) (2)
Uromodulin in a Pathway Between Decreased Renal Urate Excretion and Albuminuria (2018) (2)
Efficacy of once daily nitrendipine in mild hypertension: comparison with placebo. (1991) (2)
Aktuální trendy ve farmakoterapii hypertenze (2017) (2)
Is There Really an Association of High Circulating Adiponectin Concentration and Mortality or Morbidity Risk in Stable Coronary Artery Disease? (2020) (2)
Systematic COronary Risk Evaluation (SCORE) and 20-year risk of cardiovascular mortality and cancer. (2020) (2)
An inverse association between serum leptin concentration and reported alcohol intake in patients with manifest vascular disease (2010) (2)
Indikace PCSK9 inhibitorů v nové léčbě hypercholesterolémie vzorném poli ČSAT (2016) (2)
Hypertriglyceridemic waist increased risk of inappropriate glucose control in patients with coronary heart disease (2014) (2)
Polygenic risk scores predict diabetic complications and their response to therapy (2019) (2)
Longitudinal trends in the prevalence of hyperuricaemia and chronic kidney disease in hypertensive and normotensive adults (2020) (2)
Triglycerides, remnant lipoprotein particles and preclinical atherosclerosis in the Czech population (1999) (2)
TRENDS IN ISCHEMIC HEART DISEASE MORTALITY IN POST COMMUNIST COUNTRIES USING THE CZECH POPULATION AS AN EXAMPLE (2008) (1)
Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs (2010) (1)
D79: The effects of mibefradil on left ventricular hypertrophy in patients with essential hypertension (1997) (1)
Elite Athletes Have Mildly Elevated Serum Bilirubin Concentrations (2020) (1)
Epidemiology of Hypertension (2008) (1)
2B.07: DIASTOLIC BLOOD PRESSURE MODIFIES THE ASSOCIATION OF URIC ACID WITH ALBUMIN/CREATININE RATIO IN PRE-METABOLIC SYNDROME (2015) (1)
(Summary of the recommendations for long-term secondary prevention after myocardial infarction) (2019) (1)
Response to Letter to the Editor entitled Oxidative Stress Participates in the Associations Between Serum Uric Acid and Albuminuria in Obesity. (2017) (1)
Left ventricular hypertrophy in females with hypertension is associated with a poor prognosis. (2018) (1)
Tuesday, 28 August 2012 (2012) (1)
Longitudinal trends in blood pressure, prevalence, awareness, treatment, and control of hypertension in the Czech population. Are there any sex differences? (2022) (1)
MS203 WHY WE ARE UNABLE TO FIND CHD GENE – apoE AN EXAMPLE (2010) (1)
The European Society of Cardiology Council on Hypertension (2015) (1)
The Czech ABI Project - prevalence of peripheral arterial disease in patients at risk using the ankle-brachial index in general practice (a cross-sectional study). (2012) (1)
Cardiac hypertrophy in hypertension. (1990) (1)
European guidelines regarding the prevention of cardiovascular disease in clinical practice: a shorter version (2008) (1)
[Hypertension in pregnancy]. (2006) (1)
Prevention of type 2 diabetes mellitus with antihypertensive drugs. (2006) (1)
Can blood pressure in the first trimester predict the development of gestational hypertensive disorders? (2011) (1)
Why rapid achievement of goal blood pressure is important in the treatment of arterial hypertension. (2019) (1)
A summary of the EAS consensus concerning the causal relationship between low-density lipoproteins and atherosclerotic cardiovascular diseases, prepared by the Board of the Czech Society for Atherosclerosis. (2018) (1)
[Recommendations for diagnosis and therapy of hyperlipoproteinemias in adulthood prepared by the Czech Atherosclerosis Society]. (1997) (1)
Dietary factors in the management of hypertension (1991) (1)
PCSK9 inhibitory – nové možnosti v léčbě hypercholesterolemie:U koho budou indikovány? Stanovisko České společnosti proaterosklerózu (2016) (1)
T01-P-006 Prediction of diabetes in individuals with impaired fasting glucose in the Czech population in the 1997/98 to 2000/01 period (2005) (1)
Normative reference ranges for echocardiographic chamber dimensions in a healthy Central European population: results from the Czech post-MONICA survey (2019) (1)
PREVALENCE OF PRIMARY ALDOSTERONISM IN A GENERAL POPULATION SAMPLE OF HYPERTENSIVE SUBJECTS. THE CZECH POST-MONICA STUDY (2019) (1)
[PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated?Czech atherosclerosis society statement]. (2016) (1)
The predictive potential of asymptomatic mild elevation of cardiac troponin I on mortality risk of stable patients with vascular disease. (2015) (1)
Hypertension and arrhythmias. A review. (1989) (1)
In memoriam: Jiří Widimský Sr. 1925–2020 (2020) (1)
High leptin status indicates an increased risk of mortality and heart failure in stable coronary artery disease. (2022) (1)
UNATTENDED AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT. DOES IT DIFFER FROM OFFICE BLOOD PRESSURE? INSIGHT FROM A RANDOM POPULATION SAMPLE (2019) (1)
Statins and hypertension (2009) (1)
Prevalence and main features of resistant hypertension in central and eastern Europe: the BP-CARE Study (2012) (1)
Reziduální kardiovaskulární riziko nemocných se stabilní ischemickou chorobou srdeční v české části studií EUROASPIRE I-IV (šestnáctileté období) (2014) (1)
The changes of secondary prevention practice in Czech post-stroke patients between 2007 and 2012/13 (2016) (1)
[ESC guidelines for treatment of cardiovascular disease in pregnancy]. (2012) (1)
Synergistic effect of sclerostin and angiotensin II receptor 1 polymorphism on arterial stiffening. (2020) (1)
C-REACTIVE PROTEIN AND THE RISK OF DEVELOPING HYPERTENSION. A POPULATION STUDY: 5C.3 (2004) (1)
Diminishing benefits of urban living for children and adolescents’ growth and development (2023) (0)
[Distribution of lipoprotein associated phospholipase A2 in Czech population and its interaction with conventional cardiovascular risk]. (2013) (0)
METABOLIC PROFILE, PATTERNS OF METABOLIC CONTROL BY TREATMENT AND RELATIONSHIPS WITH BLOOD PRESSURE VALUES IN PATIENTS FROM CENTRAL AND EASTERN EUROPEAN COUNTRIES: THE BP-CARE METABOLIC STUDY: 1B.03 (2011) (0)
Metabolic profile and control by treatment and relationships with blood pressure values in patients from central and easter European countries: the BP-CARE metaboli study (2011) (0)
MRI/CT: Evaluation of Brain Damage in Hypertension (2015) (0)
Latest developments in the management of resistant hypertension (2018) (0)
Adherence to cardiovascular prevention principles in subjects at high risk. (2020) (0)
WHAT SERUM URIC ACID LEVELS ARE ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK? THE CZECH POST-MONICA STUDY (2019) (0)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension^Chinese Hypertension League Stroke in Hypertension OptimalTreatment randomized trial (2014) (0)
THE IMPORTANCE OF AORTIC PULSE WAVE VELOCITY FOR CARDIOVASCULAR RISK STRATIFICATION: PP.22.196 (2011) (0)
Educational inequalities in serum cholesterol in the Czech Republic between 1987 and 1997 (2001) (0)
THE RELATIONSHIP OF LARGE ARTERY PROPERTIES WITH HOMOCYSTEINE LEVELS IN HEALTHY SUBJECTS: P2.161 (2004) (0)
Resistant Hypertension: Definition, Prevalence, and Cardiovascular Risk (2013) (0)
Výskyt rizikových faktorů kardiovaskulárních onemocnění v brněnské populaci – pilotní studie Kardiovize Brno 2030. Závěrečná zpráva o řešení programového projektu podpořeného IGA MZ ČR (2012-2015). Brno 2016. (2016) (0)
Souhrn konsensu EAS, týkajícího se kauzálního vztahu mezi lipoproteiny o nízké hustotě a aterosklerotickými kardiovaskulárními onemocněními, zpracovaný výborem České společnosti pro aterosklerózu. (2018) (0)
PREDICTING LONG-TERM SURVIVAL AFTER AN ISCHEMIC STROKE. THE ESH-STROKE SURVEY (2022) (0)
Working group on epidemiology & prevention of the european society of cardiology (1998) (0)
Sekundární prevence u nemocných po ischemické CMP (2015) (0)
In Memoriam: Jiří Widimský Sr. 1925-2020. (2021) (0)
Doporučení diagnostikcých a léčebných postupů arteriálníhypertenze - verze 2007. Doporučení České společnosti prohypertenzi. (2008) (0)
Working group on epidemiology & prevention of the european society of cardiology (1998) (0)
EPIDEMIOLOGY OF HYPERTENSION AND DIABETES – RESULTS FROM A POPULATION SURVEY: P1.66 (2000) (0)
P-405: Hypertension after liver transplantation. A prospective follow-up study of ABPM and echocardiography (2001) (0)
CHRONIC KIDNEY DISEASE AND SURVIVAL AFTER FIRST ISCHEMIC STROKE. CROATIAN COHORT OF THE ESH STROKE SURVEY (2021) (0)
Dyslipidemie u medikamentózně léčených hypertoniků v České republice v období 1997/1998 až 2006-2009 (2012) (0)
Účinnost a snášenlivost nifedipinu XL u nemocných s arteriálníhypertenzí (2000) (0)
Novinky v terapii rezistentní hypertenze (2018) (0)
Serum Bilirubin in the Czech Population (2020) (0)
A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) (0)
CHRONIC KIDNEY DISEASE AND MORTALITY – DATA FROM THE CROATIAN COHORT OF THE ESH STROKE SURVEY (2019) (0)
4.5: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CENTRAL TO BRACHIAL BLOOD PRESSURE AMPLIFICATION IN PATIENTS TYPE 2 DIABETES MELLITUS (0)
P189 IS HIGH ANKLE-BRACHIAL INDEX PREDICTOR OF INCREASED CARDIOVASCULAR RISK? THE CZECH POST-MONICA STUDY (2010) (0)
PREVALENCE OF CHRONIC KIDNEY DISEASE IN THE GENERAL CZECH POPULATION. CZECH POST-MONICA STUDY: PP.8.214 (2011) (0)
Current trends in drug treatment of hypertension (2017) (0)
Epidemiological Aspects (Prevalence and Risk of Heart Failure Related to Blood Pressure) (2019) (0)
Opinion of the Committee of the Czech Society for Atherosclerosis on the ESC/ EAS Recommendations for Dyslipidemia Diagnostics and Treatment 2016 (2017) (0)
5th Central European Meeting on Hypertension. October 22–25, 2009, Zagreb, Croatia (2009) (0)
Epidemiology of Hypertension and Brain Disease (2016) (0)
Effects of the menopause on blood pressure. A population study (2006) (0)
European recommendations for cardiovascular disease prevention in clinical practice (2012 version) (2013) (0)
[Our first observations on transluminal recanalization of limb arteries (author's transl)]. (1979) (0)
CARDIOVASCULAR RISK FACTORS BY BLOOD PRESSURE CATEGORIES IN A CZECH POPULATION RANDOM SAMPLE. CROSS-SECTIONAL DATA AND LONGITUDINAL TRENDS: 7D.10 (2011) (0)
HYPERTENSION PREVALENCE AND BP LEVELS IN THE CZECH REPUBLIC AND POLAND: P2.396 (2004) (0)
[Recommendations for diagnostics and treatment of arterial hypertension--version 2004. Recommendations of the Czech Society for Prevention of Hypertension]. (2004) (0)
Mo-P5:356 Cardiovascular risk factors in two Czech female population samples (2006) (0)
Invited review Epidemiology and risk of hypertension (2009) (0)
[Standards of diagnosis and therapy in arterial hypertension]. (1997) (0)
Blood pressure control in the general and high risk populations, longitudinal trends (2021) (0)
T01-P-020 Logarithmically transformed ratio of triglyceride/HDL-cholesterol as an indicator of the atherogenic risk in the Czech population (2005) (0)
PROGRESSION OF HIGH-NORMAL BLOOD PRESSURE TO HYPERTENSION IS ASSOCIATED WITH HIGHER C-REACTIVE PROTEIN AT BASELINE: 3A.3 (2004) (0)
Young Investigators Awards Session (2010) (0)
Prevention of arterial hypertension. Introduction. (2005) (0)
Hodnocení výsledků měření krevního tlaku třemi různými neinvazivními metodami (2013) (0)
Assessment of Total Cardiovascular Risk in Hypertension: The Role of Subclinical Organ Damage (2012) (0)
913 COMMON GENETIC BACKGROUND FOR HYPERTENSION, METABOLIC SYNDROME TRAITS AND RESTING HEART RATE IN MICROALBUMINURIC SUBJECTS (2012) (0)
W11-P-006 The metabolic syndrome and smoking status: A population-based study (Czech post-Monica study) (2005) (0)
HYPERTRIGLYCERIDEMIC WAIST AND EXERCISE IN A FEMALE NEWFOUNDLAND POPULATION (2003) (0)
Highlight from International Congress (2006) (0)
Hypertensive disorders (2018) (0)
Prevention and epidemiology (2011) (0)
INFLUENCE OF CENTRAL AND PERIPHERAL ARTERIAL STIFFNESS ON THE TIMING AND AMPLITUDE OF REFLECTED PRESSURE WAVE: PP.10.405 (2010) (0)
EFFECT OF ANTIHYPERTENSIVE TREATMENT ON AORTIC STIFFNESS IN A GENERAL POPULATION: PP.10.415 (2010) (0)
Patterns of nicotine dependence in current smokers in KardioVize study, Brno, Czech Republic 2013–14 (2015) (0)
URINARY UROMODULIN IN A PATHWAY BETWEEN DECREASED URINARY URIC ACID EXCRETION AND ALBUMINURIA (2018) (0)
Mild chronic hypertension in pregnancy: to treat or wait? (2022) (0)
Reply. (2020) (0)
[PP.LB01.03] THRESHOLD FOR DIAGNOSING HYPERTENSION BY AUTOMATED OFFICE BLOOD PRESSURE USING RANDOM SAMPLE POPULATION DATA (2016) (0)
n g l a d r n a l of m e d i c i n e Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (2017) (0)
ANALYSIS OF RISK PROFILE, TREATMENT AND CONTROL OF HYPERTENSION IN A CZECH POPULATION SAMPLE AND IN A BLOOD PRESSURE CLINIC: P1.65 (2000) (0)
Mo-P1:13 Changes of development of the risk factors of CVD in Czech republic (Czech-post-monica study) (2006) (0)
Is a high prevalence of low HDL-cholesterol the key to high cardiovascular mortality in females of New-foundland? (1993) (0)
Abstract: 590 CHANGES OF RELATIVE IMPORTANCE OF DIFFERENT RISK FACTORS FOR MYOCARDIAL INFARCTION OVER TIME IN THE CZECH POPULATION (2009) (0)
Soluble receptor for advanced glycation end-products and aortic stiffness in general population (2015) (0)
[Recommended diagnostic and therapeutic approach in arterial hypertension--2007 version. Recommendations of the Czech Hypertension Society]. (2008) (0)
PROGRESSION TO HYPERTENSION IN THE CZECH POST-MONICA STUDY: 10-YEAR FOLLOW-UP: PP.7.297 (2010) (0)
PP.29.01: PREVALENCE AND RELATIONSHIP BETWEEN HYPERTENSION AND OBESITY IN BRNO. RESULTS FROM KARDIOVIZE 2030 BRNO (2015) (0)
Association between endothelial NO synthase polymorphism and aortic stiffness (2012) (0)
Why COLM and ACCOMPLISH study results differ. (2014) (0)
INFLUENCE OF GENDER AND EDUCATION ON PREVALENCE, AWARENESS AND CONTROL OF HYPERTENSION IN THE CZECH POPULATION: P3.100 (2000) (0)
VASCULAR REMODELING OF RETINAL VESSELS IN PATIENTS WITH CONGESTIVE HEART FAILURE (2019) (0)
PHYSIOLOGICAL CHANGES IN BLOOD PRESSURE DURING PREGNANCY (2019) (0)
K JAKYM HODNOTAM MAME SNIZOVAT KREVNI TLAK? VYSLEDKY STUDIE HOT (1999) (0)
Cardiovascular risk factors in two Czech female population samples (2006) (0)
T04-P-002 Differences of the trend of the nutrition in Czech smokers and nonsmokers (10 years research) (2005) (0)
Hypertrophic remodelling of retinal arterioles in patients with congestive heart failure (2021) (0)
[PP.09.04] REFERENCE VALUES OF CARDIO-ANKLE VASCULAR INDEX IN A RANDOM SAMPLE OF A CAUCASIAN POPULATION (2017) (0)
N-terminal pro B-type natriuretic peptide as prognostic marker for mortality in coronary patients without clinically manifest (2009) (0)
[Latent ischaemic disease in workers of the motor car industry with a high risk score (author's transl)]. (1981) (0)
Quality of Life Predictors in Chronic Stable Post-Stroke Patients and Prognostic Value of SF-36 Score as a Mortality Surrogate (2015) (0)
P6230Gender disparities in serum uric acid levels associated increased cardiovascular risk. The Czech Post-MONICA study (2019) (0)
[How to explain the decrease in coronary heart disease mortality]. (2011) (0)
INCREASING TRENDS IN DIABETES AND PRE-DIABETIC DISORDERS AMONG CZECH CORONARY PATIENTS IN EUROASPIRE STUDIES (2008) (0)
Serum cholesterol changes participate in ischemic heart disease mortality rate in the Czech population during last decade (2001) (0)
[Echocardiographic study of regression in the enlarged heart muscle during effective and long-term antihypertensive treatment]. (1985) (0)
W16-IS-001 Assessment of global cardiovascular risk (2005) (0)
M.436 The differences in nutrition of the inhabitants of the Czech Republic (subject to age and gender) (2004) (0)
The scope of hypertension (2005) (0)
W11-P-004 The metabolic syndrome in a Czechpopulation random sample: A Czech post-Monica study (2005) (0)
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels (2019) (0)
ENDOTHELIAL FUNCTION AND BLOOD PRESSURE IN LIVER TRANSPLANT RECIPIENTS: P1.142 (2000) (0)
Time trends in the relation between the achieved education and the cardiovascular risk factors prevalence and control in general population and in persons with coronary heart disease (2020) (0)
Arterial Occlusive Dissease with Hypertension as a Possible Risk Factor (1980) (0)
514 LOW ANKLE-BRACHIAL INDEX IS ASSOCIATED WITH CHRONIC KIDNEY DISEASE (2011) (0)
WO16-OR-5 RECENT CHANGES OF RISK FACTORS OF CHD IN THE CZECH POPULATION (2007) (0)
[Results of a 2-year examination of patients with essential hypertension and left ventricular hypertrophy]. (1988) (0)
Congenital adrenal hyperplasia (CAH) in adulthood (2016) (0)
THE ASSOCIATION BETWEEN METABOLIC SYNDROM AND AORTIC STIFFNESS IN GENERAL POPULATION: PP.10.387 (2010) (0)
[OP.7C.09] SYNERGISTIC EFFECT OF LOW K AND D VITAMIN STATUS ON ARTERIAL STIFFNESS IN A GENERAL POPULATION (2017) (0)
IS THE TRIGLYCERIDE-TO-HDL CHOLESTEROL RATIO A MARKER OF METABOLIC SYNDROME? (2007) (0)
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network. (2023) (0)
[Incidence of diseases of the circulatory arteries in men with a high-risk profile]. (1983) (0)
Abstracts: ECG (Arrhythmias) (2009) (0)
[Hypertension in females]. (2015) (0)
[Hypertension in pregnancy]. (2006) (0)
Low vitamin K status, high sclerostin and mortality risk of stable coronary heart disease patients. (2021) (0)
Léčba hypertenze u pacientů s diabetes mellitus 2 . typu (2019) (0)
MS354 INFLUENCE OF PERIPHERAL ARTERIAL DISEASE ON LOWER EXTREMITY ARTERIAL STIFFNESS. THE CZECH POST-MONICA STUDY (2010) (0)
REFERENCE VALUES OF RETINAL MICROCIRCULATION PARAMETERS IN A WHITE POPULATION RANDOM SAMPLE. CZECH POST-MONICA STUDY (2019) (0)
Gender differences in secondary prevention of coronary heart disease: Far from closing the gap. (2022) (0)
PARAMETERS OF PRESSURE WAVE REFLECTION ARE ASSOCIATED WITH ANKLE- BRACHIAL INDEX IN THE GENERAL POPULATION: PP.35.179 (2011) (0)
The influence of endothelial nitric oxide synthase polymorphisms and current smoking on large artery stiffness (2008) (0)
Current status of secondary prevention in Czech coronary patients in the EUROASPIRE V Study (2019) (0)
[Recommendations of diagnostic and therapeutic approaches in arterial hypertension--the year 2000 version. Recommendations of the Czech Society for Hypertension]. (2000) (0)
Recent non-HDL cholesterol and ischemic heart disease mortality in the Czech population (2001) (0)
Úroveň sekundární prevence cévních mozkových příhod u českých pacientů ve studii EUROASPIRE III – Stroke Specifi c Module * (2008) (0)
ESH statement on detection and punishment of abstract fraud and poster plagiarism. (2006) (0)
C-REACTIVE PROTEIN AND THE RISK OF DEVELOPING HYPERTENSION. THE CZECH POST-MONICA STUDY: 5B.07 (2010) (0)
Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (0)
2022 Summary of recommendations for long-term secondary prevention after myocardial infarction (2022) (0)
Residual cardiovascular risk in patients with stable coronary heart disease over the last 16 years (Czech part of the EUROASPIRE I–IV surveys) (2014) (0)
[Spanish adaptation of the European guidelines on cardiovascular prevention (and II)]. (2004) (0)
High Ankle-Brachial Index Is Associated with Increased Aortic Pulse Wave Velocity: The Czech Post-Monica Study (2009) (0)
T04-P-010 Thyroid dysfunction and dyslipidemia a population-based study (2005) (0)
T01-P-005 Hyperuricemia — The forgotten component of metabolic syndrome? (2005) (0)
EFFECTS OF SLOW DEEP BREATHING ON SHORT-TERM CHANGES IN BLOOD PRESSURE, HEART RATE AND O2 SATURATION AT ALTITUDE (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Renata Cífková?

Renata Cífková is affiliated with the following schools: